Video from AACC: Siemens Healthineers’ NAFLD test

By Leo O'Connor, Editor in Chief
July 28, 2022

Siemens Healthineers CMO Charles Cooper spoke to us about the firm’s Enhanced Liver Fibrosis blood test and how it can be used to assess the risk of nonalcoholic fatty liver disease (NAFLD) progression and liver-related events.

Click on the video below for the interview.

Siemens Healthineers at AACC

Siemens Healthineers CMO Charles Cooper.

If you like this content, please share it with a colleague!

Related Reading

Video from AACC: Thermo Fisher CMO on the future of diagnostics
Thermo Fisher Scientific featured a broad array of diagnostic testing products at AACC 2022. Chief Medical Officer (CMO) Manoj Gandhi caught up with ScienceBoard.net's...

Video from AACC: BrightInsight's Connected Diagnostics Platform
BrightInsight has launched the Connected Diagnostics Platform for the in vitro diagnostics manufacturer and the laboratory. The platform consists of four...

Video from AACC: Cloud-connected point-of-care diagnostics
Lonnie Adelman, CEO and founder of iAssay, and Dean Wong, investor and advisor to the firm, talked to LabPulse.com (sister site of ScienceBoard.net)...

Siemens Healthineers unveils in vitro diagnostics systems at AACC 2022
At AACC 2022 on Tuesday, Siemens Healthineers unveiled the Atellica CI 1900 Analyzer, a clinical chemistry and immunoassay testing system and lower volume...

Video from AACC: Lab Ordering Cloud software
Mehdi Maghsoodnia, CEO of 1health, spoke to ScienceBoard.net's sister site LabPulse.com about the market needs for the firm’s Lab Ordering...